🔗 Share this article

Treasury head Rachel Reeves has announced she is preparing "targeted action to deal with household expense pressures" in the forthcoming Budget.

During an interview with media outlets, she noted that reducing inflation is a shared duty of both the government and the central bank.

The United Kingdom's inflation rate is expected to be the highest among the Group of Seven advanced economies this calendar year and next.

Potential Utility Bill Interventions

Reports indicate the administration could take action to bring down utility costs, such as by cutting the present 5% level of VAT applied on energy supplies.

A further option is to cut some of the government charges currently added to household expenses.

Budgetary Limitations and Expert Expectations

The administration will obtain the latest assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will show how much room there is for such measures.

The consensus from most experts is that the Chancellor will have to declare higher taxes or budget cuts in order to fulfill her self-imposed fiscal targets.

Earlier on Thursday, estimates showed there was a twenty-two billion pound deficit for the Treasury chief to resolve, which is at the lower end of forecasts.

"It is a joint responsibility between the Bank of England and the government to bear down further on some of the causes of inflation," Reeves stated to reporters in the US capital, at the conferences of the IMF and World Bank.

Revenue Commitments and Global Concerns

While a great deal of the attention has been on likely tax rises, the Treasury chief said the latest figures from the fiscal watchdog had not changed her pledge to election pledges not to increase tax levels on income tax, VAT or social security contributions.

She blamed an "uncertain global environment" with growing geopolitical and trade tensions for the fiscal tax moves, probably to be targeted on those "wealthiest."

International Trade Disputes

Referring to worries about the United Kingdom's trade ties with China she said: "The UK's national security invariably come first."

Recent declaration by China to increase trade restrictions on critical minerals and other materials that are key for high-technology manufacturing led US President the US President to suggest an additional 100% tariff on imports from the Asian country, increasing the prospect of an all-out trade war between the two global powers.

The US Treasury Secretary described the Chinese action "commercial pressure" and "a international production control attempt."

Questioned on considering the American proposal to join its dispute with China, the Chancellor said she was "extremely troubled" by Chinese actions and urged the Chinese government "not to put up barriers and restrict access."

She said the move was "damaging for the world economy and generates additional obstacles."

"In my view there are sectors where we need to challenge China, but there are also valuable opportunities to sell into Chinese markets, including banking sector and other sectors of the economy. We've got to achieve that balance appropriate."

The Treasury chief also stated she was collaborating with other major economies "regarding our own critical minerals plan, so that we are reduced dependence."

NHS Drug Pricing and Funding

The Chancellor also recognized that the price the National Health Service spends on drugs could rise as a result of ongoing negotiations with the US government and its pharmaceutical firms, in return for reduced taxes and funding.

A number of the world's largest pharmaceutical manufacturers have said recently that they are either delaying or canceling operations in the United Kingdom, with several blaming the modest returns they are getting.

Recently, the government science advisor said the cost the health service pays for medicines would must go up to prevent businesses and pharmaceutical investment leaving the UK.

The Chancellor informed media: "It has been observed due to the pricing regime, that medical research, innovative medicines have not been offered in the UK in the extent that they are in other EU nations."

"We want to make sure that patients receiving treatment from the NHS are able to access the top essential medicines in the world. And so we are reviewing all of that, and... aiming to obtain additional capital into Britain."